SUNDARARAJAN JAYACHANDRAN M.D NPI 1447226444

NPI Details

Sundararajan Jayachandran, M.D is an urology in Glendale, AZ with 50 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Sundararajan Jayachandran, M.D NPI is 1447226444. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

5750 W THUNDERBIRD RD
SUITE C300
GLENDALE, AZ
ZIP 85306-660
Phone: (602) 368-3045
Fax: (602) 651-1389

The NPI 1447226444 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Urinalysis, manual test (HCPCS:81002)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test for gardnerella vaginalis (bacteria), quantification (HCPCS:87512)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Biopsy of prostate gland (HCPCS:55700)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure (HCPCS:88377)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope (HCPCS:52214)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Destruction of prostate tissue using radiofrequency induced heated water vapor (HCPCS:53854)
• Insertion of tube into ureter using an endoscope through bladder area (HCPCS:52005)
• Dilation of bladder and urethra using an endoscope (HCPCS:52341)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 2/28/2006 and was last updated on 12/10/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.